Abstract: Objective Analysis how the blood flow frequency change on cirrhosis patients by spectral Doppler ultrasound and Fibroscan. Methods Hepatitis B patients with cirrhosis (130 cases) and healthy physical examination controls (80 cases) were examined, using pulse doppler ultrasonic measurement in hepatic vein blood flow spectrum of patients with liver cirrhosis, and divided pectrum wave form into type 0 and type 1, type 2, Fibroscan tests were used at the same time. Results The numerical value (26.74, 18.60, 45.35, 43.18, 38.64, 81.82) on decompensated and decompensated cirrhosis group HV1 (%), HV2 (%) and HV1 ＋ HV2 (%) are significantly higher than the control group (8.75, 0, 8.75, P ＜ 0.001), the Fibrorscan numerical value (11.80 ± 4.30, 17.60 ± 5.73) significantly higher than the control group (4.90 ± 1.36, P ＜ 0.001), as the HV0 (%) (54.65, 18.18) significantly lower than the control group (91.25, P ＜ 0.001). Conclusions Take advantage of the Fibroscan and the wave form changes, can be meaningful to the cirrhosis evaluation and the therapeutic method choice, also as the predictor of prognosis. It is an another way to evaluate the cirrhosis in a analgesia, noninvasive condition.